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Inhibitor  of DNA  synthesis (IDS)  ~  is a glycoprotein  of approximately 80,000  mol wt 
and  isoelectric  point  2.5-3.0,  produced  in  vitro  by  concanavalin A (Con  A)-activated  nor- 
real  rat lymphocytos or  by lymphocytes from a donor immunized with antigen in vivo 
subsequently rechallenged  with  the same antigen in vitro  (1,  2).  We previously  demon- 
strated  that  IDS completely inhibits  phytohemagglutinin-induced  DNA  synthesis  of  rat 
lymphocytes  and  the  proliferation  of  a mouse fibroblast  cell  line  (L  cells;  1).  In  both  cases 
the effect  was not due to  cytotoxicity  and was completely or  partially  reversible.  IDS is 
synthesized  by  lymphocyte subpopulations demonstrating  suppressor  cell  activity  and  is 
seen in large amounts in situations  where nonspecific suppressor cell activity  is 
enhanced, such as after intravenous injection  of large tolerogenic  doses of protein 
antigens (3).  Thus, IDS may play a significant  role  in the nonspecific  suppression of 
immune responses associated  with prolonged high  levels  of  antigenic  stimulation,  as in 
competition  of  antigens (4),  parasitic  infections  (5),  or  tumors (6). 
In analyzing the mechanism of action of IDS, we were struck by the fact  that in 
lymphocytes, IDS is  inhibitory  only  when present  during  a discrete  time  interval  during 
the mitogen response, namely, between 16 and 24 h after  adding mitogen (1).  To see 
whether this  fnding could  be  related  to  a general  cell  cycle  specificity  of  IDS action,  we 
undertook the studies  described  below using L dells  synchronized by various methods. 
During the course of  these studies,  evidence was obtained showing that IDS activated 
adenylate cyclase  and  raised  intracellular  cAMP levels  of  lymphocytes (7);  consequently, 
the role  of  cAMP in  IDS action  was also  investigated. 
The term "chalone" is often  used for inhibitory  substances produced by various 
tissues  that control  the growth rate  of  those same tissues,  all of  which show cell  cycle 
specificity  and some  of  which  have  been  shown to  act  by  altering  cAMP/cGMP levels  (8). 
IDS may, therefore,  be included in this  group as a lymphocytic chalone. It would, 
however, be the first  such substance that does not demonstrate strict  tissue  specificity 
because it  also  works on fibroblasts.  The fact  that IDS produced  by lymphocytes is  also 
active  on fibroblasts  is one of  many examples in which cells  such as fibroblasts  have 
been shown to produce or respond to  factors  usually associated  only  with lymphocytes. 
The most obvious,  and somewhat trivial  example, is  lymphotoxin, a factor  produced  by 
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lymphocytes that  kills  a  variety of target cells  (9).  In addition,  fibroblasts  and other 
nonlymphoid  cells  can  be  stimulated  to  proliferate  by  macrophages  (10)  and  under 
appropriate conditions can make migration inhibitory factor (11) and nonspecific helper 
cell factors for an antibody response  (12).  These findings may reflect an as yet poorly 
defined  interaction  between  these  cell  types  in controlling  inflammation  or,  alterna- 
tively,  may represent  a  common ancestry of the  two cell types or the  adaptation  and 
refmement by the lymphocytes of a  primitive factor associated with cell recognition or 
growth control. Cultured fibroblast cell lines,  unlike lymphocytes, offer a homogeneous 
population of cells that are long-lived in vitro and readily synchronized, making them 
ideal targets to study cell cycle phenomena. 
Materials and Methods 
Production of IDS.  IDS was produced in the supernate of Con A-stimulated rat thymocytes 
or lymph node cells as described earlier (1, 3). Briefly, the cells were cultured at a density of 5 x 
106 cells/ml  in 50 ml RPMI supplemented with 10% fetal calf serum (FCS) and 2 ~g/ml Con A for 
48  h at  37°C.  The cells  were then washed and recultured in  serum-free and mitogen-free RPMI for 
an additional  48-72 h. The supernate was collected  at 24-h intervals,  concentrated on an Amicon 
Diaflo apparatus (Amicon Corp.,  Lexington, Mass.) with a UM-20 membrane, and fractionated 
on Sephadex G-100 (Pharmacia Fine Chemicals, Piscataway, N.J.).  Active fractions  were further 
purified by preparative isoelectric  focusing for 48 h at 1,000  V  on an LKB-8100 column (LKB 
Instruments, Inc.,  Rockville,  Md.) in I% ampholine solution  with a pH range of  2.5-4.0,  dialyzed 
against large  volumes of  RPMI for  48  h, and assayed on  L cells  (see  below) in  a final  concentration 
of  25% in each microwell. In most cases the supernate was concentrated 10-fold,  representing the 
lowest concentration of  IDS that when tested  in a 1:4  final  dilution  in the microwell inhibited  I 
cell  or Con A-stimulated lymphocyte DNA  synthesis more than 90%; and this  concentration was 
used in all  experiments. Control fluids,  prepared and purified  the same way except with mitogen 
added only at  the end of  culture,  showed little  or no inhibitory  activity. 
Assay oflDS in  L Cells. The A-9 subline of  mouse L cells  (13;  kindly donated by Dr. Nancy 
H. Ruddle, Department of  Epidemiology and Public Health, Yale University School of  Medicine) 
was maintained as a monolayer culture in plastic  flasks  in Eagle's minimum essential  medium 
supplemented with antibiotics  and 10% FCS. To test  IDS, cells  from a flask  of exponentially 
growing cells  were treated with Viokase (VioBin Corp., Monticello, Ill.),  washed, counted, and 
resusponded to 2.5 × 106  cells/ml  and 0.02  ml (5 × 104  cells)  added to individual  microtiter  wells 
along  with a final  concentration of  10% FCS plus the  supernatant fraction  being  tested.  The total 
volume was brought to 0.08  ml with RPMI, and the cells  were incubated for  the desired time at 
37°C. DNA  synthesis was assayed by adding 1 ~Ci of  tritiated  thymidine (spec  act 2 Ci/mmol) 
during the final  24 h and counting the trichloroacetic  acid (TCA)-precipitable radioactivity  (I). 
In some experiments,  inhibition  of L-cell  proliferation  by IDS was assayed by mitotic  index. 
Cells  were arrested in  metaphase by adding I ~g/ml colcemid, usually for  4 h, and the  percentage 
of  cells  in mitosis counted on aceto-orcein-stained  slides. 
Synchronization  of  L Cells.  L cells  were synchronized by one of  three methods. (a) Mitotic 
shake off:  This method is  based on the fact  that L cells  during mitosis round up and detach from 
the substrate, and thus relatively  pure populations of mitotic cells  can be collected  without 
perturbing  the population  (14, 15). L  cells  were grown in glass 16-oz prescription  bottles in 
calcium-free medium (16)  until nearly confluent monolayers were obtained. After washing the 
monolayer gently to remove dead or floating  clumps of  cells,  the growth medium was collected 
every 15 rain  for several hours, the collected  cells  being kept in an ice bath in the interim. (b) 
Excess thymidine:  Excess thymidine blocks cells  in S phase by feedback inhibition  of several 
enzymes necessary for nucleotide conversion (17).  A  double block technique was used (18)  in 
which a final  concentration of  5 mM  thymidine was added to a flask  of  exponentially growing L 
cells  for 18 h, the block was released for 12 h (putting all  cells  in G~) and then reapplied for an 
additional  18 h to arrest  all  cells  at the  start  of  S. (c)  Serum starvation:  Serum is  essential  for  L- 
cell  proliferation,  with cells  grown without serum block primarily at a point in G~ ("Go";  19, 20). 
L cells  were placed in a serum-free medium for 48 h, after which growth was stimulated by 
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After synchronization, cells were counted and dispensed into microtiter plates or glass vials, 
IDS or control solution added, and DNA synthesis or intracellular cAMP levels measured at 2- to 
4-h intervals thereafter. 
cAMP Assay.  Intracellular levels of cAMP were measured on senicated cell samples using a 
commercial radioimmunoassay kit (Schwarz/Mann Div.  Becton, Dickinson & Co.,  Orangeburg, 
N.Y.).  2  x  105 L cells were grown in 1 dram flat-bottomed glass vials in a  final volume of 0.5 ml 
RPMI with 10%  FCS along with the agents to be tested.  At the end of the desired incubation 
period,  the  cells  were  centrifuged  at  room  temperature  (1,500  rpm  for  2  rain),  the  medium 
aspirated,  and the cell pellet immediately frozen in ethanol-dry ice and stored at  -20°C  until 
assay.  To assay,  the cells were resuspended  in  1 ml of 0.05 N  sodium  acetate buffer,  pH  6.2, 
boiled for 8  min to  inactivate phosphodiesterase,  sonicated for 2  rain with a  cup  horn device 
(model W185,  Heat Systems-Ultrasonics, Inc.,  Plainview, N.  Y.),  centrifuged (3,000 rpm for 15 
rain),  and  300  ~1  of  the  supernate  recovered  for  the  radioimmunoassay.  This  method  is 
considerably  easier  than  conventional  methods  which  include  TCA  precipitation  and  ether 
extraction of the material before assay.  Table I  shows,  however,  that our simplified method is 
quite reliable, as addition of exogenous cAMP, adenylate cyclaso activators or phosphodiesterase 
inhibitors,  or  increasing  the  number  of cells  assayed,  produce  the  appropriate  increase  in 
intracellular cAMP levels, and all activity is destroyed by phosphodiesterase. 
Results 
Effect  of IDS  on  DNA  Synthesis  and  Mitotic  Index  of Synchronized  L 
Cells.  As previously reported, IDS inhibits DNA synthesis in L cells. In an 
attempt to localize this activity to a particular point of the cell cycle, IDS was 
added to cells synchronized by various means and DNA synthesis quantitated 
by 2-  or 4-h pulses therafter.  L  cells synchronized by mitotic shake-off and 
grown without IDS show a clearly defined peak of DNA synthesis, lasting from 
10 to 18 h after mitosis, which represents S phase (Fig. 1 a). This S phase DNA 
synthesis is  essentially completely absent  in  cells grown in the presence of 
IDS.  Panel  b  shows  that  L  cells  synchronized  by  excess  thymidine  have 
TABLE  I 
Validation of Cyclic AMP Assay on L  Cells* 
Sample  pmoles of cAMP 
5  x  10  ~ cells  0.18, 0.17 
......  +  2 pmol cAMP  1.6,  1.7 
......  +  10/zg/ml PGEI  1.5,  1.3 
......  +  5  ×  10 -s  M  IBMX  0.38, 0.38 
......  +  IBMX +  PGE1  2.9, 2.6 
......  (treated with phospho-  <0.02 
diesterase) 
......  +  PGEI  (treated with  <0.02 
phosphediester- 
ase) 
25  x  10  ~ cells  0.60, 0.65 
* L  cells  seeded  in  glass  vials  in  medium  containing  10%  FCS  4  h 
before assay. Samples harvested 15 rain before adding PGE1 or IBMX. 
Addition of exogenous cAMP in line 2 was made immediately before 
harvest.  For  phosphodiesterase  treatment,  10  tzg/ml  of 3,5  cyclic 
nucleotide phosphediesterase  (Sigma Chemical  Co.,  St.  Louis,  Mo.) 
was  added  to  sonicated  cell  suspensions  for  1  h,  after  which  the 
samples were boiled for 8 rain to inactivate the enzyme, and assayed. 
Duplicate values are shown. 174 
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Fro.  1.  Effect  of IDS on DNA synthesis at various times in synchronized L cells. Control, 
; IDS, ----.  (a) Mitotic shake-off; (b) excess thymidine; (c) serum starvation. Points 
shown are at midpoint of sequential 2- (panel a) or 4-h (panels b and c) tritiated thymidine 
pulses. Mean -+ SE of duplicate microwells. Phases of the cell cycle corresponding to the 
data are shown above. 
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initially high levels of DNA synthesis, which rapidly decline and then reach a 
peak again about 20 h later. When IDS is present, there is no effect on the first 
peak of DNA synthesis, but the second peak is significantly inhibited. Finally, 
in panel c,  L cells afar serum starvation resume DNA synthesis after a 8- to 
12-h  lag period after the addition of serum.  IDS added along with the serum 
completely inhibited this DNA synthesis, but had little effect if added 4 or 8 h 
after serum. 
The timing  of the  IDS effect was further defined by experiments  in which 
IDS  was  added  at  various  times  after  mitotic  shake-off and  S  phase  DNA 
synthesis  (Fig.  2) or mitotic index (Table II) were measured. In both instances 
IDS was equally effective when added at 0 or 6 h  after mitosis, but had little 
effect if added at the start of S phase (10 h  after mitosis). IDS added at 0 and 
removed at 6 h was also without effect. 
Effect of lDS on Intracellular cAMP Levels of Synchronized L Cells.  Initial 
evidence that IDS might act by altering intracellular cAMP levels was obtained 
by studying the effect of isebutyl-methylxanthine  (IBMX), a phosphodiesterase 
inhibiter, and imidazole, a phosphodiesterase activator, on IDS-induced inhibi- 
tion  of  DNA  synthesis.  As  seen  in  Fig.  3,  the  slight  inhibition  of  DNA 
synthesis  seen using  a  suboptimal  dose of IDS  is greatly  potentiated  by 5  x 
10 -4  M  IBMX.  Similarly,  the  inhibition  produced  by  higher  doses  of IDS  is 
partially overcome by 5 ×  10 -a M imidazole. However, when we looked directly A.  B.  WAGSHAL,  B.  V.  JEGASOTHY,  AND  B.  H.  WAKSMAN  175 
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FIG.  2.  Effect of IDS added and removed at different times on DNA synthesis in L cells 
synchronized  by mitotic  shake-off.  C,  control supernate.  Mean  _  SE of duplicate  micro- 
wells. 
TABLE  H 
Effect of IDS on L-Cell Mitosis* 
Presence of IDS  Mitotic index 
h 
Control  42,  41 
0-6  46,  41 
0-  2,  1 
6-  1,4 
10-  27,  30 
* L cells synchronized by mitotic shake-off were grown in duplicate in 
microtiter  plates  containing  IDS  during  the  indicated  times.  Col- 
cemid,  1 ~g/ml, was added at 20 h, and the cells harvested and fixed 
at  24  h.  A  total  of 300  cells  were  counted  on  aceto-orcein-stained 
slides.  Mitotic index between 4 and 16 h  was 7-9%. 
at alterations  in cAMP levels in unsynchronized  L  cells after treatment with 
IDS, no effect could be seen at any times between 2 min and 3 h  after adding 
IDS, even in the presence of IBMX, which magnifies the action of any adenylate 
cyclase activator by inhibiting the breakdown of the cAMP once formed (data 
not shown). This is despite the fact that with our assay system other adenylate 
cyclase activators gave significant increases in cAMP levels (Table I). 
One explanation for this lack of effect was that IDS only raised cAMP levels 
during the narrow portion of the cell cycle where it was effective in inhibiting 176  INHIBITOR  OF  DNA  SYNTHESIS  AND  THE  CELL  CYCLE 
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Fzo.  3.  Effect of phosphodiesterase-active agents on L-cell DNA synthesis. L  cells were 
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imidazole (5  x  10  -3 M) with a  terminal 4-h pulse of tritiated thymidine. Mean _+  SE  of 
duplicate microwells. 
DNA synthesis, and thus its effect would not be apparent in an unsynchronized 
population. Using L cells synchronized by the same three methods, we located 
a distinct time interval during which IDS will cause a  significant, sustained 
elevation of cAMP.  This  time  in  all  three methods of synchronization was 
approximately 4 h before S phase (Fig. 4), and thus corresponds with the phase 
of the cell cycle when IDS was effective in  inhibiting DNA synthesis. This 
finding is  further supported  by the  experiment in  Fig.  5  in  which L  cells 
synchronized by mitotic shake-off were pulse-treated for 15 min with IDS in 
the presence of IBMX.  IDS produced a threefold increase in cAMP at 8 h after 
mitosis, but had no effect at any other time tested. 
Discussion 
The results presented here show that II)S-induced elevation of intracellular 
cAMP level and inhibition of DNA synthesis occur only during the late G1 MGt 
$; 
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SE of triplicate cultures. Phases of the cell cycle correspond to those in Fig. 1. 
phase of the cell cycle in L cells. Our previous studies (1) have shown that IDS 
action on mitogen-stimulated lymphocytes is also limited to late  G1 when a 
similar elevation of intracellular cAMP is seen (7). Thus, this observation is 
not a specific property of lymphocytes or mitogen-induced DNA synthesis but a 
general characteristic of IDS action. In both cell types the inhibition of DNA 
synthesis appears to be totally explicable by the  increased cAMP levels.  A 
correlation between high cAMP and low proliferation was previously shown in 
a  variety  of cell  types,  including fibroblasts  and  lymphocytes  (21-23).  In 
agreement with other investigators  (24-26),  we found striking variations of 
intracellular cAMP with the phase of the cell cycle, the highest levels occurring 
during early G1 followed by a rapid fall and lower levels during late G1 and S 
phase. Our data support the concept that the fall in cAMP during late G1 may 
act as a  "trigger" to initiate DNA synthesis because IDS acts essentially to 
prevent this fall. With regard to the mechanism behind this cell cycle specificity, 
we have preliminary evidence that receptors for IDS, discerned by the ability 
of cells to absorb IDS activity from a  supernate,  are present on lymphocytes 
only approximately 16 h after mitogen stimulation (unpublished observations). 
The cell cycle specificity shown by IDS has interesting implications, cAMP 
itself  plays  a  number  of different  roles  in  a  wide  variety  of cell  types, 
particularly as the second messenger for different hormones, in addition to its 
role in shutting off proliferation.  An obvious question is how these diverse 
effects of cAMP can coexist within the same cell. This is particularly important 
in the case of IDS, which is produced by suppressor cells in situations where 
functional  evidence  of immunologic suppression  is  seen.  It  thus  would be 178  INHIBITOR  OF  DNA  SYNTHESIS  AND  THE  CELL  CYCLE 
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M IBMX to inhibit breakdown of newly formed cAMP, and tubes were then harvested for 
cAMP assay. Mean __- SE of triplicate cultures. 
expected to  bind  to  its  target  cell  and  raise  cAMP  levels  only  when  the 
consequence would be suppression of that cell's function. 
The phase of the cell cycle appears to play a  key role in determining the 
different functional consequences of raising cAMP. The best understood exam- 
ple of this is the lymphocyte. There is considerable evidence that the resting 
(Go) lymphocyte before being activated is  in a  stage of the cell cycle where 
cAMP exerts a positive growth stimulus, as opposed to the negative stimulus 
exerted by  cAMP  during the  mitogenic response,  as  seen  with  IDS.  Thus 
MacManus et al.  (27, 28) have shown that increasing the intraceUular cAMP 
concentration by a  variety of agents causes DNA synthesis and mitosis in a 
subpopulation of thymocytes. Similarly in peripheral lymphocytes, Smith et al. 
(29) have shown that one of the first observable changes after adding mitogen 
is a transient increase in cAMP level. That this increase may be significant for 
the mitogenic response is suggested not only by its universal presence after 
stimulation with a  wide variety of mitogens (21) but also by the fact that it A.  B.  WAGSHAL,  B.  V.  JEGASOTHY,  AND  B.  H.  WAKSMAN  179 
appears to be responsible for most of the other early events of the mitogen- 
activated lymphocyte (30, 31). Sulfhydryl compounds such as 2-mercaptoetha- 
nol,  which  increase  mitogen-induced DNA  synthesis,  appear  to  do  so  by 
increasing the magnitude of this early rise in cAMP concentration (32). 
Conversely, thymic hormones, which act on immature lymphocytes to make 
them more responsive to subsequent mitogen activation but inhibit ongoing 
mitogen responses, also appear to act by raising cAMP (33-35).  As previously 
shown, dibutyryl cAMP and prostaglandin E1 (PGE0 can duplicate these effects 
of thymic hormone, but IDS cannot (36), suggesting another benefit to limiting 
IDS susceptibility to mitogen-activated mature lymphocytes. 
Another persuasive example of cell cycle specificity is provided by Cloudman 
melanoma.  Like  most other  cell  lines,  these  cells  show inhibition of DNA 
synthesis in the G~ phase by added cAMP. They also show increased melaniza- 
tion (increased tyrosinase activity and melanin content) by either cAMP itself 
or melanocyte-stimulating hormone, a  poptide hormone that raises cAMP in 
melanocytes and is thought to effect melanization thereby (37-38).  However, 
melanocyte-stimulating hormone does not effectively inhibit DNA synthesis, 
and  has  been  shown  to  bind  to  melanoma cells,  raise  cAMP  levels,  and 
increase tyrosinase activity only during the G2 phase of the cell cycle. Thus 
melanoma cells  have  effectively dissociated the  two  arms  of the  action  of 
cAMP-growth  inhibition  and  increased  melanization-by  placing  them  in 
different phases of the  cell  cycle,  so  that  melanocyte-stimulating hormone, 
which binds only during G2 will cause melanization without inhibiting growth. 
Thus, by analogy, the cell cycle specificity of IDS action may be significant in 
limiting IDS action to suppression. 
Summary 
IDS inhibits DNA synthesis and mitosis of L cells only when present during 
the late G1 phase of the cell cycle, as shown with L  cells synchronized by a 
variety  of methods.  This  corresponds  well  with  earlier  findings  that  IDS 
inhibits  DNA  synthesis  in  mitogen-stimulated lymphocytes when  present 
between 16 and 24 h  at~r adding mitogen. In both cell types, the inhibition 
produced by IDS appears to be totally the result of elevation of cAMP level. 
Thus,  inhibitors of cAMP phosphodiesterase work synergistically with IDS, 
and  activators of cAMP phosphodiesterase overcome the  inhibition by IDS. 
This paper shows that IDS raises cAMP levels in L cells only within a narrow 
interval of the cell cycle, around 6-8 h after mitosis. This cell cycle specificity, 
which may be related to appearance of receptors for IDS only at discrete times, 
may be  important in limiting IDS action to  suppression, as elevated cAMP 
levels have a variety of other effects during other phases of the cell cycle. 
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